2012
DOI: 10.1016/j.imlet.2012.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical analysis of the epitope specificities of anti-C1q autoantibodies accompanying human lupus nephritis reveals them as a dynamic population in the course of the disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 50 publications
1
13
0
Order By: Relevance
“…It is shown that several positively charged viral and bacterial peptides and proteins (Quaratino et al, 1995;Wucherpfennig and Strominger, 1995;Hausmann et al, 1999) can mimic sequentially unrelated positively charged autoantigens of human proteins (e.g. myelin basic protein, proteins of ribonucleoprotein complex Ro/La, C1q) (Routsias and Tzioufas, 2010;Stoyanova et al, 2012;Mameli et al, 2014), and can activate autoreactive T and B cell responses (Vaughan et al, 1995;Wucherpfennig and Strominger, 1995;Sospedra et al, 2005). However, sometimes, just like in the case of nuclear antigens and Hu7ap, cross-reactivity between autoantigens and the inducer of the autoantibodies cannot be detected (Vaughan et al, 1995).…”
Section: Discussionmentioning
confidence: 99%
“…It is shown that several positively charged viral and bacterial peptides and proteins (Quaratino et al, 1995;Wucherpfennig and Strominger, 1995;Hausmann et al, 1999) can mimic sequentially unrelated positively charged autoantigens of human proteins (e.g. myelin basic protein, proteins of ribonucleoprotein complex Ro/La, C1q) (Routsias and Tzioufas, 2010;Stoyanova et al, 2012;Mameli et al, 2014), and can activate autoreactive T and B cell responses (Vaughan et al, 1995;Wucherpfennig and Strominger, 1995;Sospedra et al, 2005). However, sometimes, just like in the case of nuclear antigens and Hu7ap, cross-reactivity between autoantigens and the inducer of the autoantibodies cannot be detected (Vaughan et al, 1995).…”
Section: Discussionmentioning
confidence: 99%
“…Those were discovered in different analyzed cohorts. [22][23][24][25] The results from the detailed biochemical analysis of the epitope specificities of polyclonal anti-C1q autoantibodies in Bulgarian LN patients showed a quite heterogeneous autoantibodies profile (see Table 1). None of the epitope specificities tested was associated with active LN.…”
Section: Anti-c1q Autoantibodiesmentioning
confidence: 99%
“…The latter suggests that the immunogene (antigen) involved in the initiation of anti-C1q autoantibody formation might be an exogenous molecule (pathogen) with a structural similarity to C1q that may initiate an autoimmune response to it on the base of molecular mimicry and cross-reactivity. 25 In regard to the common isotype of anti-C1q antibodies in a LN patient's sera, autoantibodies from the IgG isotype are predominantly detected, with a higher affinity in comparison to IgM. The high potential valency of the polymeric IgM molecule enhances the recruitment of more MBL and C1q, therefore promoting phagocytosis, 26 associated with lower risk for an autoimmune condition.…”
Section: Anti-c1q Autoantibodiesmentioning
confidence: 99%
See 1 more Smart Citation
“…The anti-C1q autoantibodies are known to be polyclonal high affinity IgG molecules, produced in an antigen-driven process [ 13 , 14 , 15 ]. The complex structure of C1q provides two types of functional domains—the N-terminal collagen-like region (CLR) and the C-terminal globular heads ghA, ghB and ghC, associated in a globular domain (gC1q).…”
Section: Introductionmentioning
confidence: 99%